Paralel Advisors LLC Purchases Shares of 85,835 Option Care Health, Inc. $OPCH

Paralel Advisors LLC acquired a new stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) in the second quarter, HoldingsChannel.com reports. The institutional investor acquired 85,835 shares of the company’s stock, valued at approximately $1,800,000.

Several other large investors have also modified their holdings of OPCH. Royal Bank of Canada boosted its position in shares of Option Care Health by 20.7% in the first quarter. Royal Bank of Canada now owns 231,161 shares of the company’s stock worth $8,078,000 after acquiring an additional 39,661 shares during the last quarter. AQR Capital Management LLC increased its position in Option Care Health by 162.6% during the first quarter. AQR Capital Management LLC now owns 41,633 shares of the company’s stock worth $1,450,000 after purchasing an additional 25,777 shares during the last quarter. Empowered Funds LLC purchased a new position in Option Care Health during the first quarter worth approximately $208,000. Invesco Ltd. raised its stake in Option Care Health by 2.7% during the second quarter. Invesco Ltd. now owns 294,363 shares of the company’s stock worth $9,561,000 after purchasing an additional 7,678 shares during the period. Finally, EverSource Wealth Advisors LLC raised its stake in Option Care Health by 528.1% during the second quarter. EverSource Wealth Advisors LLC now owns 1,407 shares of the company’s stock worth $46,000 after purchasing an additional 1,183 shares during the period. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Option Care Health Stock Performance

Shares of OPCH opened at $24.21 on Monday. Option Care Health, Inc. has a 12 month low of $18.01 and a 12 month high of $36.80. The stock’s 50-day moving average is $22.80 and its two-hundred day moving average is $24.79. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.47 and a quick ratio of 0.98. The stock has a market cap of $3.63 billion, a PE ratio of 18.20, a P/E/G ratio of 1.40 and a beta of 0.61.

Option Care Health (NASDAQ:OPCH) last posted its earnings results on Wednesday, July 29th. The company reported $0.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.43 by $0.02. The business had revenue of $1.44 billion during the quarter, compared to analyst estimates of $1.42 billion. Option Care Health had a return on equity of 18.74% and a net margin of 3.68%.The company’s revenue for the quarter was up 1.9% compared to the same quarter last year. During the same quarter last year, the firm earned $0.41 earnings per share. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. Equities analysts forecast that Option Care Health, Inc. will post 1.69 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several analysts have recently issued reports on OPCH shares. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $24.00 price objective (down from $26.00) on shares of Option Care Health in a research note on Thursday, July 30th. The Goldman Sachs Group started coverage on Option Care Health in a research report on Monday, June 8th. They set a “neutral” rating and a $22.00 price target for the company. Zacks Research upgraded Option Care Health from a “strong sell” rating to a “hold” rating in a research note on Monday, July 6th. Stephens restated an “equal weight” rating and issued a $24.00 price objective (down from $30.00) on shares of Option Care Health in a report on Friday, July 17th. Finally, Wall Street Zen raised Option Care Health from a “hold” rating to a “buy” rating in a research note on Saturday, August 1st. Seven equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Option Care Health has a consensus rating of “Hold” and a consensus price target of $29.92.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.